Cargando…

Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease

Parkinson’s disease (PD) is a clinically heterogeneous disorder with a multi-factorial pathology. Various molecular mechanisms are involved in the pathogenesis of PD, converging to oxidative stress and proteinopathy. The accumulation of reactive aldehydes (i.e., the dopamine metabolite DOPAL, lipid-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masato, Anna, Sandre, Michele, Antonini, Angelo, Bubacco, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977628/ https://www.ncbi.nlm.nih.gov/pubmed/33535956 http://dx.doi.org/10.2174/1570159X19666210203162617

Ejemplares similares

Scavenging neurotoxic aldehydes using lysine carbon dots
por: Bloch, Daniel Nir, et al.
Publicado: (2023)

Smell deficits in COVID-19 and possible links with Parkinson's disease
por: Emmi, Aron, et al.
Publicado: (2022)

The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018)

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
por: Masato, Anna, et al.
Publicado: (2019)

Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
por: Agostini, Francesco, et al.
Publicado: (2021)

Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
por: De Lazzari, Federica, et al.
Publicado: (2018)

Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease
por: Zhao, Xin, et al.
Publicado: (2013)

Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism
por: Chiu, Ching-Chi, et al.
Publicado: (2014)

Blood Glutamate Scavenging: Insight into Neuroprotection
por: Leibowitz, Akiva, et al.
Publicado: (2012)

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
por: Streubel-Gallasch, Linn, et al.
Publicado: (2021)

Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson’s disease: implication of acrolein and TRPA1
por: Shi, Liangqin, et al.
Publicado: (2021)

Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?
por: Bisaglia, Marco, et al.
Publicado: (2020)

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
por: Sulzer, David, et al.
Publicado: (2020)

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
por: Russo, Isabella, et al.
Publicado: (2014)

Effects of Solvent Polarity on the Reaction of Aldehydes and Ketones with a Hydrazide-Bound Scavenger Resin
por: de Oliveira, Alline V. B., et al.
Publicado: (2019)

Parkinson’s disease and immune system: is the culprit LRRKing in the periphery?
por: Greggio, Elisa, et al.
Publicado: (2012)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2023)

Ceramides in Parkinson’s Disease: From Recent Evidence to New Hypotheses
por: Plotegher, Nicoletta, et al.
Publicado: (2019)

DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease
por: Masato, Anna, et al.
Publicado: (2023)

Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
por: Filograna, Roberta, et al.
Publicado: (2016)

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
por: Sarkar, Sumit, et al.
Publicado: (2016)

Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data
por: Torres, Napoleon, et al.
Publicado: (2017)

Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
por: Curry, Daniel W., et al.
Publicado: (2018)

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
por: Błaszczyk, Janusz W.
Publicado: (2018)

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
por: Gundersen, Vidar
Publicado: (2021)

α-Synuclein Toxicity in Drosophila melanogaster Is Enhanced by the Presence of Iron: Implications for Parkinson’s Disease
por: Agostini, Francesco, et al.
Publicado: (2023)

Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
por: Greggio, Elisa, et al.
Publicado: (2011)

Optimal risk stratification and therapeutic strategy for acute myocardial infarction
por: Imamura, Teruhiko
Publicado: (2021)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson’s Disease
por: Anastassova, Neda, et al.
Publicado: (2022)

Neuroprotective properties of dietary saffron: more than just a chemical scavenger?
por: Skladnev, Nicholas V., et al.
Publicado: (2017)

Facile preparation of a novel biogenic silver-loaded Nanofilm with intrinsic anti-bacterial and oxidant scavenging activities for wound healing
por: Bardania, Hassan, et al.
Publicado: (2020)

Structure-oriented substrate specificity engineering of aldehyde-deformylating oxygenase towards aldehydes carbon chain length
por: Bao, Luyao, et al.
Publicado: (2016)

Salivary Aldehyde Dehydrogenase: Activity towards Aromatic Aldehydes and Comparison with Recombinant ALDH3A1
por: Giebułtowicz, Joanna, et al.
Publicado: (2009)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Who Cares about Biogenic Amines?
por: Esposito, Luigi, et al.
Publicado: (2023)

Bacterial melanin in rat models of Parkinson's disease: a potential neuroprotective strategy
por: Petrosyan, Tigran
Publicado: (2015)

Phytochemical Characteristics, Free Radical Scavenging Activities, and Neuroprotection of Five Medicinal Plant Extracts
por: Chang, Chia Lin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lrck0fkrip2s0sc7k02fr6ql3m